Influencia de los antiinflamatorios no esteroideos en la hemorragia digestiva por úlceras o erosiones gastroduodenales en pacientes con cirrosis hepática

Castro‐Fernández, Manuel; Sánchez-Muñoz, Diego; Galán-Jurado, M.V.; Larraona, J. L.; Suárez, Emilio; Lamas, Eloisa; Rodríguez-Hornillo, M.C.; Pabón, Manuel

doi:10.1157/13083251

Cited by 20 publications

(7 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 969 They are responsible for 10% of cases of drug-induced hepatitis 970 and are reported to cause hepatotoxicity. 957 , 971 Furthermore, NSAIDs can cause side effects such as nephrotoxicity, 972 gastric ulcers or bleeding, 973 , 974 and decompensation 964 in patients with liver cirrhosis; therefore, their use must be avoided as much as possible. In patients with bone metastasis, COX-2 inhibitors (rofecoxib, celecoxib, valdecoxib) are used to alleviate pain by inhibiting prostaglandin synthesis.…”

Section: Drug Treatment For Cancer Pain In Hccmentioning

confidence: 99%

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

2023

JLC

View full text Add to dashboard Cite

dance of new research findings and therapies for HCC have been presented and published in South Korea and around the globe. As many studies have been conducted, a substantial amount of knowledge have been accumulated on the diagnosis, staging, and treatment of HCC specific to Asia, with the study results showing different clinical behaviors from the West, especially in South Korea; these new research find- KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinomaKorean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea*

show abstract

Section: Drug Treatment For Cancer Pain In Hccmentioning

confidence: 99%

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

2023

JLC

View full text Add to dashboard Cite

show abstract

“…Indeed, roughly 10% of total drug-induced hepatotoxicity cases are related to NSAIDs,709 and NSAID-induced liver injury is well documented 695,710. Moreover, NSAIDs can cause adverse effects, including nephrotoxicity,711 gastric ulcer, hemorrhage,59,60,712,713 and decompensation of liver function 703…”

Section: Drug Treatment For Cancer Pain In Hccmentioning

confidence: 99%

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Park¹,

Lee²,

Suh³

et al. 2019

Gut and Liver

274

185

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.

show abstract

“…Indeed, roughly 10% of total drug-induced hepatotoxicity cases are related to NSAIDs (709), and NSAID-induced liver injury is well documented (695710). Moreover, NSAIDs can cause adverse effects, including nephrotoxicity (711), gastriculcer, hemorrhage (5960712713), and decompensation of liver function (703).…”

Section: Drug Treatment For Cancer Pain In Hccmentioning

confidence: 99%

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

2019

Korean J Radiol

204

128

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology, and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.

show abstract

Influencia de los antiinflamatorios no esteroideos en la hemorragia digestiva por úlceras o erosiones gastroduodenales en pacientes con cirrosis hepática

Cited by 20 publications

References 18 publications

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Contact Info

Product

Resources

About